Focus Partners Wealth
GILD icon

Focus Partners Wealth’s Gilead Sciences GILD Stock Holding History

Focus Partners Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.1M Sell
475,579
-74,999
-14% -$9.88M 0.06% 278
2026
Q1 		$76.7M Buy
550,578
+29,925
+6% +$4.19M 0.09% 223
2025
Q4 		$63.8M Buy
520,653
+131,310
+34% +$16M 0.07% 245
2025
Q3 		$43.2M Buy
389,343
+240,095
+161% +$27.3M 0.07% 234
2025
Q2 		$16.5M Buy
149,248
+6,582
+5% +$700K 0.04% 400
2025
Q1 		$16M Buy
142,666
+6,522
+5% +$673K 0.04% 377
2024
Q4 		$12.6M Buy
136,144
+33,456
+33% +$3.01M 0.03% 413
2024
Q3 		$8.61M Sell
102,688
-44,452
-30% -$3.39M 0.03% 440
2024
Q2 		$10.1M Buy
147,140
+84,455
+135% +$5.64M 0.03% 388
2024
Q1 		$4.59M Buy
62,685
+9,983
+19% +$768K 0.04% 334
2023
Q4 		$4.27M Buy
+52,702
New +$4.1M 0.06% 254

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Focus Partners Wealth's GILD Position: Q2 2026 in Review

Focus Partners Wealth reduced its Gilead Sciences (GILD) stake by 14% in Q2 2026, selling an estimated $9.88M and leaving 475,579 shares worth $60.1M. The position accounts for 0.06% of the portfolio, ranked #278.

Focus Partners Wealth first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $76.7M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Focus Partners Wealth held 475,579 shares of Gilead Sciences worth $60.1M as of Q2 2026.
  • Focus Partners Wealth sold 74,999 Gilead Sciences shares in Q2 2026, an estimated $9.88M.
  • Gilead Sciences made up 0.06% of Focus Partners Wealth's portfolio in Q2 2026, its #278 holding.
  • Focus Partners Wealth first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Focus Partners Wealth's Gilead Sciences position peaked at $76.7M in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.